Brookfield Corporation Announces Pricing of C$1 Billion of Medium-Term Notes

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES

BROOKFIELD, NEWS, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Brookfield Corporation (NYSE: BN, TSX: BN) today announced the pricing of a public offering of C$1 billion aggregate principal amount of medium-term notes (“notes”), comprised of C$350 million aggregate principal amount of medium term notes due March 1, 2033, which will bear interest at a rate of 4.388% per annum, payable semi-annually and C$650 million aggregate principal amount of medium term notes due December 11, 2055, which will bear interest at a rate of 5.399% per annum, payable semi-annually.

The notes are expected to be assigned a credit rating of A- by Standard & Poor’s, A- by Fitch, A3 by Moody’s and A by DBRS.

Brookfield Corporation intends to use the net proceeds from the sale of the notes to fund the previously announced redemption of its 4.82% medium term notes due January 28, 2026 and any remainder will be used for general corporate purposes.

The notes are being offered through a syndicate of agents led by CIBC Capital Markets, RBC Capital Markets, TD Securities, BMO Capital Markets, National Bank Financial Markets and Scotiabank.

The notes are being offered under an existing base shelf prospectus filed in Canada. The offering is being made only by means of a prospectus supplement and pricing supplements relating to the offering of the notes. You may obtain these documents for free on SEDAR+ at www.sedarplus.ca. Before you invest, you should read these documents and other public filings by Brookfield Corporation for more complete information about Brookfield Corporation and this offering.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction, nor shall there be any offer or sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been approved or disapproved by any regulatory authority nor has any such authority passed upon the accuracy or adequacy of the short form base shelf prospectus, the prospectus supplement or the pricing supplements. The offer and sale of the securities has not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold in the United States or to United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.